✦ LIBER ✦

HBeAG loss among chronic hepatitis B HBeAG positive patients treated with lamivudine in a clinic setting

✍ Scribed by H.W.L. Hann; D.M. Rosenberg; M.L. Funk; S. Hawley; R. Davis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ALT normalization and loss of HBV DNA am

✍ H.W.L. Hann; M.L. Funk; D.M. Rosenberg; S. Hawley; R. Davis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Predictors for early HBeAg loss during l

✍ Cheng-Yuan Peng; Chih-Bin Chen; Hsueh-Chou Lai; Wen-Pang Su; Po-Heng Chuang; Hon 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 188 KB

Lamivudine therapy in HBeAg negative chr

✍ Guclu, E.; Batirel, A.; Ince, N. Koc; Ogutlu, A.; Durmaz, Y.; Ozdemir, D.; Geyik 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Extended lamivudine treatment in patient

✍ Mario Rizzetto; Nicholas C. Tassopoulos; Robert D. Goldin; Rafael Esteban; Teres 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Histological improvement in HBeAg positi

✍ Patrick Marcellin; Zack Goodman; Ting-Tsung Chang; Seng Gee Lim; Myron Tong; Wil 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Frequent occurance of lamivudine resista

✍ H. Bozkaya; C. Yurdaydin; A.M. Bozdayi; N. Aslan; H. Verdi; K. Çinar; H. Çetinka 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 126 KB